Jetzt noch länger handeln: 7:30 - 23:00
Mit uns direkt oder auf gettex.
Über Deinen Broker oder Deine Bank.

Bellevue F (Lux) Bellevue Obesity Solutions B USD

WKNA0RPSP
AssetklasseAktien
458,675+1,38
+0,30%
14.11.2025 21:47
458,675+1,38
+0,30%
14.11.2025 21:47
Verkaufen
455,347VerkaufenStück: 30
Kaufen
464,909KaufenStück: 30
Eröffnung
448,561
Hoch
458,675
Tief
448,561
Fund seeks to achieve long-term capital growth by investing at least two-thirds of the net assets in a portfolio of carefully chosen shares and preference shares of companies whose business is directed towards the prevention and treatment of overweight or obesity and their secondary conditions or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. The Fund invests in biotech equities worldwide but mainly US.
Emittent
Waystone Management Company (Lux) SA
Benchmark
NASDAQ Biotechnology TR
Fondsgröße in Mio.
32,98
Gesamtkostenquote (TER)
2,17 %
Tracking Difference
1,372
Replikation
-
Fondswährung
USD
Domizil
LU
Fondsauflage
-
Ausschüttung
Thesaurierend
Ausschüttungsintervall
-
NAV
532,15
NAV Datum
13.11.2025